On 19 April 2007, Merck signed a partnership agreement with the World Health Organization, to supply 200 million tablets of Cesol® 600 (praziquantel) for the treatment of schistosomiasis over a 10-year period. The Merck donation, with an estimated value of approximately USD 80 million, should allow the treatment of 80 million schistosomiasis cases over the lifetime of the program.
The donation will address the issue of the affordability of praziquantel, which has been a barrier to access in poor communities and the main obstacle to implementing preventive anthelminthic chemotherapy in many African countries. Anthelminthic chemotherapy refers to drug treatment for worm infections, such as schistosomiasis, that disrupt the metabolism of the worms responsible, also known as helminths.
|Location||Eastern Africa, Central Africa, Southern Africa, West Africa, Angola, Cameroon, Congo, The Democratic Republic of, Ethiopia, Madagascar, Mali, Nigeria, Senegal, Sudan, Tanzania, Zimbabwe|
|Value||USD 80 Million|